Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
cell therapy
Biotech
After sealing reverse merger, Carisma aims for cancer wins
Carisma Therapeutics is plotting a busy 2023 now that its merger with Sesen Bio is officially in the rearview.
Max Bayer
Mar 21, 2023 11:20am
Bellicum's GoCAR-Ts crash out, sparking hunt for strategic exit
Mar 15, 2023 7:50am
2-protein knockout helps T-cell therapies hit harder
Mar 14, 2023 9:20am
Vertex's next off-the-shelf diabetes therapy ready for clinic
Mar 9, 2023 10:30am
Creative Medical taps Syneos to run diabetes cell therapy study
Mar 9, 2023 4:30am
Replay, MD Anderson form near-clinical TCR-NK cell therapy firm
Feb 14, 2023 9:30am
